$1.5M sweet spot round size
Most of their 162 investments are in rounds between $27M and $105M
2012
ROME Therapeutics raised $72M on September 12, 2023
Investors: Bristol-Myers Squibb, UK, Sanofi Ventures, GV, Section 32 and Casdin Capital, LLC
Thyme Care raised $60M on August 21, 2023
Investors: Frist Cressey Ventures, Andreessen Horowitz, AlleyCorp, Foresite Capital, Town Hall Ventures and Casdin Capital, LLC
Octave Bioscience raised $30M on July 26, 2023
Investors: Section 32, Northpond Ventures, Hikma Ventures, Intermountain Ventures, ECHO and Casdin Capital, LLC
Orbital Therapeutics raised $270M on April 26, 2023
Investors: Heritage Medical Systems, Newpath Partners, ARCH Venture Partners, Redmile Group, Exor N.V., iGlobe Partners, The Invus Group and Casdin Capital, LLC
Function Oncology raised $28M on April 12, 2023
Investors: Andreessen Horowitz, Section 32 and Casdin Capital, LLC
iVexSol raised $24M on January 26, 2023
Investors: BioLife Solutions, Bristol-Myers Squibb, UK, Asahi KASEI Medical Europe GmbH and Casdin Capital, LLC
Nest Genomics (YC W22) raised $8.5M on January 10, 2023
Investors: iAngels, Arkin Digital Health, B Capital Group, Maven, Y Combinator, Data Collective and Casdin Capital, LLC
Asimov raised $175M on January 5, 2023
Investors: KdT Ventures, Pillar VC, Andreessen Horowitz, Horizons Ventures and Casdin Capital, LLC
Undisclosed raised $15M on December 8, 2022
Investors: Viking Global Investors and Casdin Capital, LLC
Undisclosed raised $20M on September 8, 2022
Investors: Illumina Ventures, Leerink Transformation Partners and Casdin Capital, LLC